CLOPIXOL ACUPHASE 50 MG 1 AMPOULE – What is it, Uses & 2026 Price in Turkey

by

Clinical Data Review: Comprehensive profile for CLOPIXOL ACUPHASE 50 MG 1 AMPOULE, including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: CLOPIXOL ACUPHASE 50 MG 1 AMPOULE

Manufacturer: LUNDBECK PHARMACEUTICALS TRADING LTD.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

ZUKLOPENTIKSOL 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

CLOPIXOL ACUPHASE 50 MG 1 AMPOULE is formulated with ZUKLOPENTIKSOL, a clinically established agent in medical practice.

  • Mechanism of Action: ZUKLOPENTIKSOL acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to ZUKLOPENTIKSOL therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name CLOPIXOL ACUPHASE 50 MG 1 AMPOULE
Barcode (GTIN) 8699795750225
Generic Name ZUKLOPENTIKSOL
License Holder LUNDBECK PHARMACEUTICALS TRADING LTD.
Pharmacy Retail Price 393.34 TL
⚠️ Clinical Safety Warning

Do not administer CLOPIXOL ACUPHASE 50 MG 1 AMPOULE if the patient has a known hypersensitivity or allergy to ZUKLOPENTIKSOL. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via LUNDBECK PHARMACEUTICALS TRADING LTD..

Leave a Comment